DYNAMICS OF CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS AS INFLUENCED BY INFLIXIMAB (REMIKEID) ADMINISTRATION
Main Authors: | E. S. Zhugrova, V. I. Mazurov, A. M. Lila, K. A. Syssoev, S. V. Lapin, Areg A. Totolian |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2014-07-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/167 |
Similar Items
-
The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study
by: M. Manara, et al.
Published: (2016-12-01) -
Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence
by: Iannone F, et al.
Published: (2022-06-01) -
Infliximab in the therapy of rheumatoid arthritis
by: G. V. Lukina, et al.
Published: (2016-05-01) -
INFLIXIMAB (REMICADE): POSSIBILITIES IN THE TREATMENT OF RHEUMATOID ARTHRITIS
by: Nataliya Vladimirovna Chichasova, et al.
Published: (2011-03-01) -
Development of Anti-bodies against Infliximab in Iraqi Patients with Rheumatoid Arthritis.
by: Mohammed A. Al-Karkhi, et al.
Published: (2015-10-01)